CN109106937A - Application of the wood frog's fallopian tube collagen peptide in eczema is antipruritic - Google Patents
Application of the wood frog's fallopian tube collagen peptide in eczema is antipruritic Download PDFInfo
- Publication number
- CN109106937A CN109106937A CN201810741828.0A CN201810741828A CN109106937A CN 109106937 A CN109106937 A CN 109106937A CN 201810741828 A CN201810741828 A CN 201810741828A CN 109106937 A CN109106937 A CN 109106937A
- Authority
- CN
- China
- Prior art keywords
- fallopian tube
- wood frog
- collagen peptide
- eczema
- tube collagen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/65—Amphibians, e.g. toads, frogs, salamanders or newts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Rheumatology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pain & Pain Management (AREA)
- Biotechnology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a kind of application of wood frog's fallopian tube collagen peptide in eczema is antipruritic, and wood frog's fallopian tube collagen peptide is used for zoopery and eczema 200 many cases of antipruritic treatment of people, as a result prove there is antipruritic effect.
Description
Technical field
The present invention relates to a kind of medical field, in particular to application of a kind of wood frog's fallopian tube collagen peptide in eczema is antipruritic.
Background technique
Phase eczema is a kind of hypersensitive inflammation skin disease, is a kind of common disease, and the cause of disease is complicated, eczema symptom it is wet out
Rash pathogenesis is related with IV allergic reaction type, i.e., delayed allergy (the Delayed Type mediated by T lymphocyte
Of Hypersensitivity, DTH), it is often the interaction of inside and outside many factors as a result, general relatively rapid, fash of falling ill
It in pleomorphism, is made of papule, erythema and bubble, edge diffuses unclear, violent itch, can be by acute, subacute recurrent exerbation
It is transformed into chronic eczema, shows as pachylosis, scratch, incrustation, has seriously affected the quality of life of patient, also resulted in patient
Psychological pressure.
The generation of eczema is the influence of internal and external environment, and the moisturizing mechanism of skin receives destruction and damages initiation, skin
Moisture content between skin tissue cell and cell is reduced, and causes cell arrangement close, the collagen dehydration hardening in skin,
When the moisture in the outermost cuticula of skin is reduced to 10% or less, skin show dry, matt and slip, corrugation,
Rough surface, flakiness, at this point, by the influence such as external environment, virus, bacterium, sunshine or the thorn of body something itself
Scytitis will be induced by swashing, and exactly this inflammation leads to red swelling of the skin, itch even pain.The water conservation moisturizing of skin is always
The research topic that skin protection cosmetics does not wane always, research and excavation can improve the soft and moist property of skin biology, slickness and water conservation and protect
Wet material is the basic condition for preventing and treating skin disease.
Summary of the invention
The present invention provides a kind of application of wood frog's fallopian tube collagen peptide in eczema is antipruritic, is found through experiments that, wood frog's fallopian tube collagen
Protein peptides have antipruritic effect to eczema.
Wood frog's fallopian tube collagen peptide has the mechanism of antipruritic effect to eczema:
Wood frog's fallopian tube collagen peptide is to repair collagen type, is play in the health and beauty of human skin very important
Role.Using technologies such as advanced orientation digestion, UF membrane, spray drying, extractions, the product extracted from collagen,
The average molecular weight of wood frog's fallopian tube collagen peptide is in 3500Da or so, the three-level superhelix of opposite collagen complexity, wood frog's fallopian tube collagen
The linear structure of peptide makes its digestibility be up to 80%.Wood frog's fallopian tube collagen peptide is the hydrolysate of collagen, is that the minimum of collagen is single
Member, structure can be expressed as (Gly-x-y), be a kind of high-purity peptide that glycine is had in N-terminal, can be by without decomposing
Absorption of human body and utilization.The component polypeptides that people are called bombesin are mainly contained in wood frog's fallopian tube skin, it have anti-inflammatory, anticancer,
Anti-aging and other effects;Wood frog's fallopian tube skin not easy infection, the features such as self-healing speed is fast, repair ability is strong after injury, all and in skin
Contained active peptide is related.Therefore, for the research of its active peptide, the development that can be used for novel functional food and drug is opened
Hair has application value and realistic meaning.
Antibacterial peptide can not only inhibit certain proinflammatories, while can also enhance certain other immune responses.Antibacterial peptide pair
The adjusting or regulation of function have apparent paradox in immune response.This characteristic that these peptides are shown in inflammatory environment
Be conducive to selectively inhibit or promote the overall balance of inflammatory reaction in host, to generate a kind of appropriate, pure resist
Infection reaction.The immunoloregulation function that antibacterial peptide is mediated be not independently of other immune responses, but formed a complexity
Immune mediator network and downstream signaling pathway, this is also necessary to defense mechanism entirety effective operation.In same antibacterial peptide phase
During interaction, they activate the key signal access that innate immunity gene function in downstream is adjusted with adjusting to some extent.It is anti-
Bacterium peptide can directly affect the activation of transcription factor, participate in the adjusting and expression of congenital immunity gene, meet functional genomics
Research.
Wood frog's fallopian tube collagen peptide can more effectively penetrate into cuticula, skin corium, effectively with its unique natural performance
Play the role of moisturizing, water conservation and water lock, plays and extend the Skin Cell service life, inhibit Cell membrane lipids peroxidating, resist oxidation
Free radical is to the attack of DNA, the activity for inhibiting tyrosine, raising cutaneous immunisation ability, raising skin water holding water holding capacity, promotion
The multiple efficacies such as the synthesis of collagen and the synthesis of dermal cell hyaluronic acid.
Detailed description of the invention
Fig. 1 is that 0.05g/kg antipruritic effect comparison diagram is once a day administered in wood frog's fallopian tube collagen peptide cream.
Fig. 2 is the mouse delayed that the high, medium and low dosage group of wood frog's fallopian tube collagen peptide cream induces 2,4-dinitrochlorobenzene
The comparison diagram that hypersensitivity (ear swelling) significantly inhibits.
Specific embodiment
Three formulas based on wood frog's fallopian tube collagen peptide carry out zoopery below, verify wood frog's fallopian tube collagen peptide to wet
The antipruritic effect of rash:
Wood frog's fallopian tube collagen peptide paste ingredient 1, mass percent:
Stearic acid 7%, single glycosides rouge 6%, propylene glycol 5%, glycerine 8%, potassium hydroxide 0.5%, P-hydroxybenzoic acid first
Ester 0.02%, wood frog's fallopian tube collagen peptide 1.5%, deionized water 71.98%.
Wood frog's fallopian tube collagen peptide paste ingredient 2, mass percent:
Glycerin monostearate 10%, single glycosides rouge 3%, octadecyl alcolol 4%, glycerine 9%, emulsifier HR-SL (alkyl phosphorus
Acid esters sylvite) 0.5%, oviductus ranae 1%, methyl p-hydroxybenzoate 0.01%, ethyl-para-hydroxybenzoate 0.01%, wood frog's fallopian tube glue
Former protein peptides 1.5%, distilled water 70.98%.
Wood frog's fallopian tube collagen peptide paste ingredient 3, mass percent:
Hydrogenate oneself 4%, glycerine 9%, panaxoside 1.5%, cream of soft phosphatide 8.5%, single glycosides rouge 5%, palm acid ethyl
Agent HR-SL (potassium alkyl phosphate) 0.5%, methyl p-hydroxybenzoate 0.01%, propylparaben
0.005%, ethyl-para-hydroxybenzoate 0.005%, wood frog's fallopian tube collagen peptide 1.5%, distilled water 69.98%.
Wood frog's fallopian tube collagen peptide paste ingredient 1, formula 2 and the animal experiment for being formulated 3
Wood frog's fallopian tube collagen peptide cream, which is once a day administered, is remarkably improved the threshold value that histamine phosphate causes cavy itch, wherein with
It is best that wood frog's fallopian tube collagen peptide cream is once a day administered 0.05g/kg antipruritic effect, the results are shown in Table 1 and Fig. 1.
Table 1: influence of the wood frog's fallopian tube collagen peptide to cavy itch-threshold
Note: P < 0.01 * * compared with blank group
The mouse delayed that the high, medium and low dosage group of wood frog's fallopian tube collagen peptide cream induces 2,4-dinitrochlorobenzene is super quick
Reaction (ear swelling) significantly inhibit, can substantially reduced allergic inflammation symptom, the results are shown in Table 2 and Fig. 2.
Table 2: the influence that wood frog's fallopian tube collagen peptide swells to mouse ear
Note: P < 0.01 * P < 0.05 compared with model control group, * *.
By above it is demonstrated experimentally that wood frog's fallopian tube collagen peptide has antipruritic effect to eczema.
In addition, wood frog's fallopian tube collagen peptide paste ingredient 1, formula 2 and formula 3 to be used for antipruritic 200 many cases of eczema of people, knot
Fruit proves there is antipruritic effect.
Claims (4)
1. application of the wood frog's fallopian tube collagen peptide in eczema is antipruritic.
2. described in claim 1 using wood frog's fallopian tube collagen peptide paste, mass percent formula are as follows:
Stearic acid 7%, single glycosides rouge 6%, propylene glycol 5%, glycerine 8%, potassium hydroxide 0.5%, methyl p-hydroxybenzoate
0.02%, wood frog's fallopian tube collagen peptide 1.5%, deionized water 71.98%.
3. described in claim 1 using wood frog's fallopian tube collagen peptide paste, mass percent formula are as follows:
Glycerin monostearate 10%, single glycosides rouge 3%, octadecyl alcolol 4%, glycerine 9%, emulsifier HR-SL0.5%, oviductus ranae
1%, methyl p-hydroxybenzoate 0.01%, ethyl-para-hydroxybenzoate 0.01%, wood frog's fallopian tube collagen peptide 1.5%, distilled water
70.98%.
4. described in claim 1 using wood frog's fallopian tube collagen peptide paste, mass percent formula are as follows: hydrogenate soft phosphatide
8.5%, oneself 4%, glycerine 9% of single glycosides rouge 5%, palm acid ethyl, panaxoside 1.5%, emulsifier HR-SL 0.5%, right
Methyl hydroxybenzoate 0.01%, propylparaben 0.005%, ethyl-para-hydroxybenzoate 0.005%, wood frog's fallopian tube collagen
Protein peptides 1.5%, distilled water 69.98%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810741828.0A CN109106937A (en) | 2018-07-09 | 2018-07-09 | Application of the wood frog's fallopian tube collagen peptide in eczema is antipruritic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810741828.0A CN109106937A (en) | 2018-07-09 | 2018-07-09 | Application of the wood frog's fallopian tube collagen peptide in eczema is antipruritic |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109106937A true CN109106937A (en) | 2019-01-01 |
Family
ID=64861995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810741828.0A Pending CN109106937A (en) | 2018-07-09 | 2018-07-09 | Application of the wood frog's fallopian tube collagen peptide in eczema is antipruritic |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109106937A (en) |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003176219A (en) * | 2001-12-13 | 2003-06-24 | Ichimaru Pharcos Co Ltd | Collagen tripeptide-containing skin care preparation |
CN101879307A (en) * | 2009-05-08 | 2010-11-10 | 冒华 | Preparation for repairing active cells |
CN102229972A (en) * | 2011-05-23 | 2011-11-02 | 长春工业大学 | Preparation method for collagen peptides from tree frog skin |
CN102579299A (en) * | 2012-03-19 | 2012-07-18 | 邱芳萍 | Chinese forest frog collagen peptide essence moisture cream and manufacture method thereof |
CN102579298A (en) * | 2012-03-19 | 2012-07-18 | 邱芳萍 | Snow frog collagen peptide myogenic skin moisturizing water and preparation method thereof |
CN102872158A (en) * | 2012-07-02 | 2013-01-16 | 马应龙药业集团股份有限公司 | External drug combination for curing eczema and preparation method thereof |
CN104873479A (en) * | 2015-05-19 | 2015-09-02 | 四川师范大学 | Collagen polypeptide skin membrane capable of reducing swelling and relieving itching and preparation method of collagen polypeptide skin membrane |
CN105919894A (en) * | 2016-06-20 | 2016-09-07 | 合肥丰瑞隆生物科技有限公司 | Biological environment-friendly liquid shampoo and preparing method thereof |
CN106176361A (en) * | 2010-12-30 | 2016-12-07 | 玫琳凯有限公司 | Topical skin composition and application thereof |
CN106333879A (en) * | 2016-11-25 | 2017-01-18 | 青岛源之林农业科技开发有限公司 | Collagen moisturizer |
-
2018
- 2018-07-09 CN CN201810741828.0A patent/CN109106937A/en active Pending
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003176219A (en) * | 2001-12-13 | 2003-06-24 | Ichimaru Pharcos Co Ltd | Collagen tripeptide-containing skin care preparation |
CN101879307A (en) * | 2009-05-08 | 2010-11-10 | 冒华 | Preparation for repairing active cells |
CN106176361A (en) * | 2010-12-30 | 2016-12-07 | 玫琳凯有限公司 | Topical skin composition and application thereof |
CN102229972A (en) * | 2011-05-23 | 2011-11-02 | 长春工业大学 | Preparation method for collagen peptides from tree frog skin |
CN102579299A (en) * | 2012-03-19 | 2012-07-18 | 邱芳萍 | Chinese forest frog collagen peptide essence moisture cream and manufacture method thereof |
CN102579298A (en) * | 2012-03-19 | 2012-07-18 | 邱芳萍 | Snow frog collagen peptide myogenic skin moisturizing water and preparation method thereof |
CN102872158A (en) * | 2012-07-02 | 2013-01-16 | 马应龙药业集团股份有限公司 | External drug combination for curing eczema and preparation method thereof |
CN104873479A (en) * | 2015-05-19 | 2015-09-02 | 四川师范大学 | Collagen polypeptide skin membrane capable of reducing swelling and relieving itching and preparation method of collagen polypeptide skin membrane |
CN105919894A (en) * | 2016-06-20 | 2016-09-07 | 合肥丰瑞隆生物科技有限公司 | Biological environment-friendly liquid shampoo and preparing method thereof |
CN106333879A (en) * | 2016-11-25 | 2017-01-18 | 青岛源之林农业科技开发有限公司 | Collagen moisturizer |
Non-Patent Citations (6)
Title |
---|
乔潇,等: "功能化多肽的研究概述", 《河北科技师范学院学报》 * |
孔惠,等: "鲑鱼鱼皮胶原蛋白小分子肽的功效性研究", 《第十一届中国化妆品学术研讨会论文集》 * |
张崟,等: "胶原蛋白酶解制备肽工艺研究进展", 《中国调味品》 * |
王长周,等: "林蛙皮胶原蛋白肽的制备工艺", 《食品工业科技》 * |
王长周: "长白山林蛙皮胶原蛋白肽的制备及其活性研究", 《中国优秀硕士学位论文全文数据库 工程科技Ⅰ辑》 * |
邱芳萍,等: "林蛙皮胶原蛋白肽酶解工艺数学建模及抗氧化作用的研究", 《食品与生物技术学报》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9782337B2 (en) | Methods and compositions using compounds from fetal cells and tissues to improve condition of skin | |
KR102295786B1 (en) | Use of bokryeong extract and its active ingredient in promoting skin care and/or wound healing | |
CN104414914A (en) | Striae gravidarum recovery essence | |
KR20200088074A (en) | Skin external composition comprising centella asiatica extract and papaver rhoeas extract | |
KR101780486B1 (en) | Cosmetic composition comprising echinacea purpurea extract | |
CN109010180A (en) | A kind of pregnant woman is dispelled scar cream with pregnant line of comforting of dispelling | |
CN108261361A (en) | A kind of anti-acne repairing paste containing Porcine HGF and preparation method thereof | |
CN106176479B (en) | Composition and its application for balancing human body inflammatory reaction and delaying skin aging disease | |
JP2016196419A (en) | External preparation for skin | |
KR20190048202A (en) | Methods for preparing nanoliposome encapsulating of N-Acetyl glucosamine and Sodium chondroitin sulfate and cosmetic composition containing the same | |
CN109106937A (en) | Application of the wood frog's fallopian tube collagen peptide in eczema is antipruritic | |
KR101824179B1 (en) | Cosmetic composition for moisturizing and anti-inflammatory effect having fermented artemisia gmelinii weber ex stechm. | |
CN107303305A (en) | A kind of nursing gel | |
Umadevi et al. | Studies on W Studies on Wound Healing Effect of ound Healing Effect of Flaveria trinervia Leaf in Mice | |
KR101894747B1 (en) | Cosmetic Material Composition Comprising the Extract of Gongjindan Ingredients and Lotus | |
JP5258993B1 (en) | Heparan sulfate production promoter | |
KR101757674B1 (en) | Cosmetic Composition Comprising Extracts of Bidens bipinnata for Enhancing Skin Tightening and Improving Skin Wrinkle | |
KR20190013418A (en) | Composition for improving skin wrinkle or skin moisturizing comprising Gryllus bimaculatus extract as effective component | |
CN107625869A (en) | A kind of traditional Chinese medicinal ointment for treating eczema | |
CN107320354A (en) | One kind nourishes equilibrium cream | |
CN107375083A (en) | A kind of toxin expelling equilibrium cream | |
US20160193139A1 (en) | Composition having A. paniculata for wound healing and skin whitening, and method by using the same | |
JP6080479B2 (en) | Preventive and therapeutic agent for herpes simplex virus infection derived from maitake extract | |
KR101115737B1 (en) | Composition containing coffee berry extracts or biter orange flower extracts | |
CN105287648B (en) | Sea is delivered vegetables the extraction preparation method and applications of active constituent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190101 |
|
WD01 | Invention patent application deemed withdrawn after publication |